Related Experiment Video
Updated: Nov 26, 2025

Lung CT Segmentation to Identify Consolidations and Ground Glass Areas for Quantitative Assesment of SARS-CoV Pneumonia
Published on: December 19, 2020
Histopathology features of the lung in COVID-19 patients
M Angeles Montero-Fernandez1,2, Ricardo Pardo-Garcia1,2
1Clinical Director of Cellular Pathology and Consultant Cardiothoracic Histopathologist, Manchester University NHS Foundation Trust, Senior Lecturer (Hon), Manchester University, Manchester, UK. Conflicts of interest: none declared.
Insights
The primary cause of death in COVID-19 patients is hypoxic respiratory failure, characterized by diffuse alveolar damage (DAD). Histopathological findings reveal distinct acute and organizing phases of DAD in lung tissues.
Area of Science:
- Pulmonary Pathology
- Infectious Diseases
- Histopathology
Background:
- COVID-19, caused by SARS-CoV-2, is a global pandemic.
- Hypoxic respiratory failure from acute respiratory distress syndrome (ARDS) is the main cause of mortality.
- Diffuse alveolar damage (DAD) is the characteristic histopathological finding in COVID-19 lung injury.
Purpose of the Study:
- To describe the histopathological features of diffuse alveolar damage (DAD) in COVID-19.
- To outline the distinct phases of DAD observed in lung specimens.
- To discuss the specificity of DAD findings in the context of other viral infections.
Main Methods:
- Histopathological examination of postmortem lung specimens from COVID-19 patients.
- Analysis of morphological changes across different disease durations.
- Comparison of DAD features with those observed in other viral pneumonias.
Main Results:
- DAD presents with distinct morphological features in acute (exudative) and organizing (proliferative) phases.
- The acute phase occurs within the first week, characterized by pulmonary injury.
- The organizing phase follows, with additional features like vascular thrombosis, endothelialitis, and angiogenesis observed.
Conclusions:
- DAD is a common histopathological finding in fatal COVID-19 cases.
- The temporal evolution of DAD shows distinct phases with varying morphological characteristics.
- The specificity of DAD in COVID-19 requires further investigation, as similar patterns are seen in other viral infections.
Abstract:
COVID-19 is the infectious disease caused by the recently discovered coronavirus, SARS-CoV-2, unknown before the outbreak in Wuhan, China, in December 2019. COVID-19 is a pandemic, infectious disease that has simultaneously affected many countries globally. The leading cause of dead in patients with COVID-19 is hypoxic respiratory failure from acute respiratory distress syndrome (ARDS). Diffuse alveolar damage (DAD) is the histopathological pattern commonly described in all the postmortem series up to date. DAD is divided into two phases, and depending on the length of the disease, the morphological features seen in the specimens vary. There is an acute/exudative phase, which occurs during the first week after the pulmonary injury, following by the organizing/proliferative phase. Additional features detailed include vascular thrombosis, endothelialitis and angiogenesis. Interestingly, there is an ongoing discussion about the specificity of these changes, as diffuse alveolar damage seen in other viral infections show similar features.
Related Concept Videos
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Pneumonia II: Pathophysiology
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
Gross Anatomy of the Lungs
Pulmonary Hypertension: Classification and Pathogenesis
There are various classifications for PH, each relating to different underlying causes and also...
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...

